A verification study for the effect of the soybean milk beverage
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000035612
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Not provided
1.Subjects who are given continuous treatment by taking medicines. 2.Subjects who have taken medicines that may have influence to intestinal environment from a month before advance inspection. 3.Subjects who constantly use food for specified health use, functional foods, supplements, and/or healthy food having a possibility of affecting intestine regulatory action. 4.Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 5.Subjects who have previous and/or current medical history of serious disease. 6.Subjects who excessive alcohol intake. 7.Subjects who have previous and/or current medical history of drug dependence, alcohol dependence. 8.Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 9.Subjects who have previous medical history of drug and/or food, allergy, especially for milk and/or soybean milk. 10.Subjects who have constitution that tend to diarrhea if they intake dairy products and/or soybean milk products. 11.Subjects who are participating the other clinical tests, who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. 12.Subjects who donated over 200mL blood and/or blood components within the last one month. 13.Males who donated over 400mL blood and/or blood components within the last three month. 14.Females who donated over 400mL blood and/or blood components within the last four month. 15.Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 16.Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 17.Others who have been determined ineligible by principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method